JP2017513856A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513856A5 JP2017513856A5 JP2016562948A JP2016562948A JP2017513856A5 JP 2017513856 A5 JP2017513856 A5 JP 2017513856A5 JP 2016562948 A JP2016562948 A JP 2016562948A JP 2016562948 A JP2016562948 A JP 2016562948A JP 2017513856 A5 JP2017513856 A5 JP 2017513856A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- pharmaceutical composition
- polypeptide
- acid peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 38
- 150000001413 amino acids Chemical class 0.000 claims 22
- 239000008194 pharmaceutical composition Substances 0.000 claims 18
- 229920001184 polypeptide Polymers 0.000 claims 18
- 102000004196 processed proteins & peptides Human genes 0.000 claims 18
- 125000003275 alpha amino acid group Chemical group 0.000 claims 13
- 239000012634 fragment Substances 0.000 claims 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 230000003779 hair growth Effects 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 4
- 208000035475 disorder Diseases 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 4
- 241000282412 Homo Species 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 3
- -1 carrier Substances 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 3
- 210000004209 hair Anatomy 0.000 claims 3
- 210000003780 hair follicle Anatomy 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 239000002537 cosmetic Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000003054 hormonal effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 2
- 206010000599 Acromegaly Diseases 0.000 claims 1
- 208000005676 Adrenogenital syndrome Diseases 0.000 claims 1
- 208000008448 Congenital adrenal hyperplasia Diseases 0.000 claims 1
- 102000018997 Growth Hormone Human genes 0.000 claims 1
- 108010051696 Growth Hormone Proteins 0.000 claims 1
- 206010020112 Hirsutism Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 claims 1
- 208000010067 Pituitary ACTH Hypersecretion Diseases 0.000 claims 1
- 208000020627 Pituitary-dependent Cushing syndrome Diseases 0.000 claims 1
- 244000099172 Prunus ilicifolia subsp ilicifolia Species 0.000 claims 1
- 235000016794 Prunus ilicifolia subsp ilicifolia Nutrition 0.000 claims 1
- OXHNQTSIKGHVBH-ANULTFPQSA-N Tetrahydrogestrinone Chemical compound C1CC2=CC(=O)CCC2=C2[C@@H]1[C@@H]1CC[C@](CC)(O)[C@@]1(CC)C=C2 OXHNQTSIKGHVBH-ANULTFPQSA-N 0.000 claims 1
- 201000005188 adrenal gland cancer Diseases 0.000 claims 1
- 208000024447 adrenal gland neoplasm Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 201000008230 cutaneous porphyria Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000000122 growth hormone Substances 0.000 claims 1
- 206010020718 hyperplasia Diseases 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229960003632 minoxidil Drugs 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 229960002036 phenytoin Drugs 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1406989.2 | 2014-04-17 | ||
| GBGB1406989.2A GB201406989D0 (en) | 2014-04-17 | 2014-04-17 | Novel treatments |
| PCT/GB2015/051165 WO2015159099A1 (en) | 2014-04-17 | 2015-04-17 | Compositions comprising osteopontin derivatives for the inhibition of hair growth |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017513856A JP2017513856A (ja) | 2017-06-01 |
| JP2017513856A5 true JP2017513856A5 (zh) | 2018-05-31 |
Family
ID=50928957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016562948A Abandoned JP2017513856A (ja) | 2014-04-17 | 2015-04-17 | 毛成長抑制のためのオステオポンチン誘導体を含む組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20170143605A1 (zh) |
| EP (1) | EP3131528A1 (zh) |
| JP (1) | JP2017513856A (zh) |
| KR (1) | KR20160136342A (zh) |
| CN (1) | CN106413734A (zh) |
| AU (1) | AU2015248652A1 (zh) |
| BR (1) | BR112016023899A2 (zh) |
| CA (1) | CA2945930A1 (zh) |
| GB (1) | GB201406989D0 (zh) |
| IL (1) | IL248084A0 (zh) |
| MX (1) | MX2016013589A (zh) |
| RU (1) | RU2016144971A (zh) |
| SG (1) | SG11201608497YA (zh) |
| WO (1) | WO2015159099A1 (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2857749T3 (es) * | 2017-05-04 | 2021-09-29 | Follicum Ab | Péptidos para el tratamiento de la diabetes |
| KR102091567B1 (ko) * | 2018-06-15 | 2020-03-20 | 인하대학교 산학협력단 | 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물 |
| EP3876970A1 (en) * | 2018-11-07 | 2021-09-15 | Follicum AB | Peptide fragments for treatment of diabetes |
| EP3692978A1 (en) * | 2019-02-07 | 2020-08-12 | DSM IP Assets B.V. | Novel method |
| WO2020161255A1 (en) * | 2019-02-07 | 2020-08-13 | Dsm Ip Assets B.V. | Novel method for reducing hair growth |
| DK3958835T5 (da) * | 2019-04-24 | 2024-06-10 | Follicum Ab | Topisk formulering |
| CN115397458B (zh) | 2020-02-25 | 2024-09-13 | 安普力菲卡控股集团公司 | 用于刺激毛发生长的组合物和方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5753612A (en) * | 1992-10-27 | 1998-05-19 | Yissum Research Development Co. Of The Hebrew University Of Jerusalem | Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists |
| US6884772B1 (en) * | 1999-10-21 | 2005-04-26 | Kao Corporation | Depilatories and agents for external use |
| EP1269196B1 (en) * | 2000-03-23 | 2007-11-21 | Glaxo Group Limited | Method of screening for inhibitors of osteopontin |
| WO2008086449A2 (en) * | 2007-01-09 | 2008-07-17 | Oregon Health & Science University | Synthetic osteopontin peptides and methods of use |
| GB2493540A (en) * | 2011-08-10 | 2013-02-13 | Follicum Ab | Agents for stimulating hair growth in mammals |
-
2014
- 2014-04-17 GB GBGB1406989.2A patent/GB201406989D0/en not_active Ceased
-
2015
- 2015-04-17 AU AU2015248652A patent/AU2015248652A1/en not_active Abandoned
- 2015-04-17 MX MX2016013589A patent/MX2016013589A/es unknown
- 2015-04-17 EP EP15721789.4A patent/EP3131528A1/en not_active Withdrawn
- 2015-04-17 CA CA2945930A patent/CA2945930A1/en not_active Abandoned
- 2015-04-17 JP JP2016562948A patent/JP2017513856A/ja not_active Abandoned
- 2015-04-17 KR KR1020167027851A patent/KR20160136342A/ko unknown
- 2015-04-17 SG SG11201608497YA patent/SG11201608497YA/en unknown
- 2015-04-17 RU RU2016144971A patent/RU2016144971A/ru not_active Application Discontinuation
- 2015-04-17 BR BR112016023899A patent/BR112016023899A2/pt not_active Application Discontinuation
- 2015-04-17 CN CN201580019288.XA patent/CN106413734A/zh active Pending
- 2015-04-17 WO PCT/GB2015/051165 patent/WO2015159099A1/en active Application Filing
- 2015-04-17 US US15/300,056 patent/US20170143605A1/en not_active Abandoned
-
2016
- 2016-09-27 IL IL248084A patent/IL248084A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017513856A5 (zh) | ||
| Tsantoulas et al. | Kv2 dysfunction after peripheral axotomy enhances sensory neuron responsiveness to sustained input | |
| RU2471867C2 (ru) | Гиалуронидаза и способ ее применения | |
| RU2014108819A (ru) | Новые композиции и их применение | |
| RU2016144971A (ru) | Композиции, содержащие производные остеопонтина для ингибирования роста волос | |
| CA2596597A1 (en) | Method for stimulation collagen synthesis and/or kgf expression | |
| HUE035584T2 (en) | A therapeutic agent for the treatment of allopathy | |
| JP2017532343A5 (zh) | ||
| CN106581641A (zh) | 一种多肽在预防或治疗心肌缺血再灌注损伤相关疾病中的药物应用 | |
| JP2017504589A5 (zh) | ||
| JPWO2019156137A5 (zh) | ||
| Rekers et al. | Stereotactic ablative body radiotherapy combined with immunotherapy: present status and future perspectives | |
| JP2014139185A5 (zh) | ||
| KR101679310B1 (ko) | 신규 펩타이드 및 성장인자 콤플렉스를 함유한 상처 재생 및 피부 진정용 화장료 조성물 | |
| JP2021073234A (ja) | 環状ペプチド並びに該環状ペプチドを含む医薬、外用剤および化粧料 | |
| IL240695B1 (en) | NME inhibitors and methods of using NME inhibitors | |
| MX2021000698A (es) | Peptidos anti-inflamatorios orales para tratar la epilepsia, convulsiones y trastornos del snc. | |
| JP2008531463A5 (zh) | ||
| ES2393125T3 (es) | Un método para estimular la angiogénesis usando DKK2 y composición que comprende la misma | |
| JP2010514669A5 (zh) | ||
| CA2755897A1 (en) | Treatment of cancers with immunostimulatory hiv tat derivative polypeptides | |
| CN113980144B (zh) | 一种多肽类似物及其应用 | |
| TWI465246B (zh) | 類鋅手指胜肽及包含其之醫藥組成物用於製備治療或預防乳癌之藥物之用途 | |
| CN102341115A (zh) | 用于预防或治疗性处理初始阶段的皮肤肿瘤的肽 | |
| CN105267530A (zh) | 一种治疗烧烫伤中成药 |